Getting to BIDMC    Contact BIDMC    617-667-7000

Events Calendar    News    CAREERS @ BIDMC

ABOUT BIDMC CENTERS & DEPARTMENTS PATIENT & VISITOR INFORMATION YOUR HEALTH QUALITY & SAFETY MEDICAL EDUCATION RESEARCH GIVE TO BIDMC
 

BIDMC Research Investigator / Faculty Information

J Thomas T Lamont MD

Professor

Gastroenterology

Faculty Appointment:

Gastroenterology

   

Contact Information:

 
Title:   Physician, Professor
Office:   DA-501
Phone:   667-8377
Fax:   667-2767
Email:   jlamont@bidmc.harvard.edu
Address:   Beth Israel Deaconess Medical Center
 330 Brookline Ave; DA-501
 Boston, MA 02215

Advanced Degree And Training Info:

Year

Institution

Area or Rank

1965  Univ of Rochester  Medicine
1971  Mass General Hospital  Fellow in GI
1975  Brigham and Women  Asst Prof
1980  Boston University Med Center  Assoc Prof Chief of GI Di
1985  Boston Univ  Prof of Medicine
1995  BIDMC Harvard Med School  Chief of GI Prof of Medic

Research Team Listing

No team members listed

Areas of Interest:

Infectious Diseases, Inflammation

Patient Oriented / Translational   

Major Research Theme:

We work on the structure and function of Clostridium difficile toxins. These protein exotoxins are among the class of enterotoxins, and they are the main virulence factor for this pathogen , the cause of pseudomembranous colitis. We are trying to elucidate the signal transduction pathways in mammalian enterocytes exposed to toxins A and B of C. difficile. The toxin receptors are surface proteins that help internalize the toxins. Toxin action involves a profound effect on mitocondrial function and activation of protein kinase c.We have also identified a membrane protein that serves as a  receptor for C difficie toxins and facilitates cell binding /internalization.

Select Major Publications:    List of Publications via PubMed database at NIH NLM

Warny et al. p38 MAP kinase activation by C. difficile toxin A J. Clin Invest 105:1147-56, 2000.
Chen M, Pothoulakis C, Lamont JT.  PKC signalling Z0-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A.  J. Biol Chem, 277: 4247-4254, 2002
Na X, Zhao D, Koon HW, Kim H, Husmark J, Moyer MP, Pothoulakis C, and Lamont JT.  Clostridium difficile Toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes. Gastroenterology, 2005; 128:1002-1011
Kim H, Kokkotou E, Na X, Rhee SH, Moyer MP, Pothoulakis C, Lamont JT.      Closstridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent-p21   (WAF1/CIP1) induction via p38 MARK. Gastroenterology 2005; In Press
Kim H, Rhee SH, Kokkotou E, Na X, Savidge T, Moyer MP, Pothoulakis C, and Lamont JT. Clostridium difficile Toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. J. Biol. Chem., 280: 21237-21245, 2005

External Recognition:

NIH Merit Award 1996-2006 , Assoc Editor NEJM , Past chair, NIH- NIDDK Subcommittee C( Training Grants Review committee). Chair, NIH-NIDDK Boundary Team in Digestive Diseases, Past Senior Assoc Editor, Gastroenterology, Member FDA Review Panel on GI Drugs.

Major Collaborative Activities:

We interact with laboratories in BIDMC ( Surgery, Endocrinology, Cardiology ) Childrens Hospital, Mass General Hospital, Boston University School of Medicine, University of Chicago and Stanford University School of Medicine

Investigator's Web Site:

             

Harvard Catalyst Site:

   
 

Copyright 2009 Beth Israel Deaconess Medical Center | Contact Research Webmaster

IP Address: 38.107.191.87   |  Web Server: research.bidmc.harvard.edu   |  Database Server: Colorado\SQL17   |  App Path: /research/ResearchPIInfo.ASP   |  Version:

Browser: CCBot/1.0 (+http://www.commoncrawl.org/bot.html)
SecurityGroup: